Gwo Xi Stem Cell Applied Technology Co., Ltd. (6704) Stock Price & Analysis
6704 Stock Chart & Stats
- Day’s Range
- TWD 19.00 - TWD 20.30
- 52-Week Range
- TWD 18.00 - TWD 28.90
- Previous Close
- TWD 20.20
- Volume
- N/A
- Average Volume (3M)
- 131.28K
- Market Cap
- TWD 2.12B
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- TWD 361.74M
- Total Debt (Recent Filing)
- TWD 353.19M
- Price to Earnings (P/E)
- ―
- Beta
- 0.10
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
6704 FAQ
What was Gwo Xi Stem Cell Applied Technology Co., Ltd.’s price range in the past 12 months?
What is Gwo Xi Stem Cell Applied Technology Co., Ltd.’s market cap?
When is Gwo Xi Stem Cell Applied Technology Co., Ltd.’s upcoming earnings report date?
Is Gwo Xi Stem Cell Applied Technology Co., Ltd. overvalued?
Does Gwo Xi Stem Cell Applied Technology Co., Ltd. pay dividends?
What is Gwo Xi Stem Cell Applied Technology Co., Ltd.’s EPS estimate?
How many shares outstanding does Gwo Xi Stem Cell Applied Technology Co., Ltd. have?
Which hedge fund is a major shareholder of Gwo Xi Stem Cell Applied Technology Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Gwo Xi Stem Cell Applied Technology Co., Ltd.
Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem cell-based therapies, addressing critical unmet medical needs in patient care. Its product pipeline currently features two pioneering autologous adipose-derived stem cell treatments: GXHPC1, which is in Phase II clinical trials for liver cirrhosis, and GXNPC1, also undergoing Phase II testing, designed for the management of chronic stroke. Further expanding its therapeutic portfolio, the company is advancing GXCPC1, an allogeneic adipose-derived stem cell therapy currently in combined Phase I/II clinical trials for osteoarthritis, alongside GXIPC1, another allogeneic fat-derived stem cell treatment in early-stage Phase I trials for diabetes. Established in 2011, the company maintains its headquarters in Zhubei, Taiwan.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Chuan-Feng Chiu
- Employees
- 55
- Website
- www.gwoxi.com
- Address
- No. 2, Shengyi 3rd Rd., Zhubei, TQ, 302041, TW
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 4 | 14 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 0 | 0 | 12 |

